NCT01351272 (BEAS) is a Phase 3 clinical trial of Methylphenidate, non-retard in ADHD, sponsored by Wuerzburg University Hospital.

Who is sponsoring NCT01351272?

NCT01351272 is sponsored by Wuerzburg University Hospital.

What drugs are being tested in NCT01351272?

Interventions in NCT01351272: Methylphenidate, non-retard, Placebo.

Is NCT01351272 still recruiting?

NCT01351272 is currently completed. Last updated 15 March 2024.

Are results published for NCT01351272?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2024-03-15 · How we verify

NCT01351272: BEAS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Genetic Modulation of Functional Brain Activity of Attention-deficit/Hyperactivity Disorder-related Working Memory Processes

Completed Phase 3 Results posted Last updated 15 March 2024

What this trial tests

Phase 3 trial testing Methylphenidate, non-retard in ADHD in 41 participants. Completed in 1 March 2013.

Timeline

1 May 2011

Primary endpoint
1 December 2012

1 March 2013

Quick facts

Lead sponsor	Wuerzburg University Hospital
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	41
Start date	1 May 2011
Primary completion	1 December 2012
Estimated completion	1 March 2013
Sites	1 location across Germany

Drugs / interventions tested

Methylphenidate, non-retard — full drug profile →
Placebo

Conditions studied

ADHD — all drugs for ADHD →

Sponsor

Wuerzburg University Hospital

Who can join

Adults 18 to 50, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Brain Activation
Time frame: 6 weeks
Functional brain activity in right Superior Frontal Gyrus (SFG) during the working memory task post treatment as measured by fMRI. For each participant and conditions the estimated parameters are metric, and can be further analysed with ANOVAs or t-tests.

Sponsor's own description

In this study the investigators will measure the functional brain activity of adult Attention Deficit Hyperactivity Disorder (ADHD) patients, genotyped according to the COMT genotype, during a Working Memory Paradigm, before and after a placebo controlled treatment with MPH for 6 WEEKS. Within this design, the investigators will be able to evaluate the therapeutic effect of MPH treatment on cognitive functions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for ADHD

Currently open trials in the same condition.

NCT07314333 — A Trial to Assess How Centanafadine Interacts With Stimulants in the Body · Phase 1 · recruiting
NCT07262853 — Dual Executive Function Training Package · NA · recruiting
NCT07291453 — Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits · NA · recruiting
NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
NCT07219810 — Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD · NA · recruiting

Other Wuerzburg University Hospital trials

Trials by the same sponsor.

NCT07084480 — Giant Cell Arteritis - Ways to Precision Medicine · recruiting
NCT07040189 — Gustabor Phase 1 - AI-based Creation of a Nutritional Plan to Compensate for Chemotherapy-induced Taste Disorders · NA · not yet recruiting
NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
NCT07108569 — Ability of Physicians to Distinguish Real From Artificial Colon Polyp Images · NA · completed
NCT06553326 — EndoStyle: Artificial Intelligence Image Transformation Tool for Colonoscopy · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01351272 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wuerzburg University Hospital
Last refreshed: 15 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01351272.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing